Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Adapting Care During COVID-19: Q&A with Brett Smith, DO

Mary Choy, PharmD, BCGP, FASHP  |  Issue: January 2021  |  November 9, 2020

I share the ACR’s COVID-19 Guidance with patients to improve adherence to immunosuppressants and build confidence in our response as a rheumatology community.

Q: How are patients currently feeling about telemedicine and in-person appointments?
Dr. Smith:
Like many other practices, we saw a surge of telemedicine visits in April and May. Prior to the pandemic, we conducted no telemedicine visits. In April, [telemedicine appointments] increased to approximately one-third of our encounters.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Now, we still have patients desiring telemedicine appointments mainly due to concern of exposure to the virus in healthcare facilities and the community. They feel connected to their physician, even through virtual visits, and feel we are acknowledging their concerns about exposure to the virus and desires for continued healthcare access.

Many patients who are on stable doses of medications and have minimal disease activity prefer telemedicine visits. But many patients prefer in-person appointments because they desire a face-to-face discussion and a complete physical examination. A positive note from the pandemic is the expanding visit options offered to patients.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

TR: What are your current plans for continuing or ending telemedicine services?
Dr. Smith:
If reimbursement continues for telemedicine, I see it being a valuable tool for physicians and patients. I would like to continue to offer telemedicine services even after the pandemic, because I believe it improves show rates for those with long travel times and for those who have jobs with changing schedules. It also allows patients to be seen when they may have fevers, family emergencies or other conflicts.

New patients should be evaluated in person, because the lack of a formal physical exam may make diagnosis and long-term management challenging. So that component will remain, even if telemedicine stays, in my clinic. I plan to continue to offer telemedicine for all established patients.

TR: What are you looking forward to doing after the pandemic is over?
Dr. Smith:
I’m personally looking forward to removing my mask in public and during office visits, recapturing the face-to-face interactions and expressions that make up a great deal of our communication.

I’m also looking forward to being able to travel with my family to various parts of the U.S.


Mary Choy, PharmD, BCGP, FASHP, is a medical writer and editor living in New York City. Dr. Choy is director of pharmacy practice at the New York State Council of Health-System Pharmacists. She is also the author of Healthcare Heroes: The Medical Careers Guide.

Page: 1 2 3 | Single Page
Share: 

Filed under:Practice SupportProfessional Topics Tagged with:COVID-19patient carePractice Management

Related Articles

    The End of the Beginning: COVID-19 Vaccines & Other Conundrums

    December 9, 2020

    “It’s like winning Powerball.” For months, there has been a steady trickle of questions from my patients, asking for my opinion about the new vaccines being developed to prevent COVID-19. More to the point, they want to know if they should be vaccinated. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEAfter some fits and starts, I finally struck…

    The Doctor Will See You Now: Legal & Regulatory Reforms Expand Telemedicine

    March 17, 2020

    In this time of COVID-19, you may be considering ways to deliver routine rheumatologic care via some form of telemedicine. Here are some of the legal considerations.

    Vax Hesitancy? Myths & Facts for Patients

    December 16, 2021

    Although more than 189,300,000 eligible Americans are fully vaccinated against SARS-CoV-2 as of Oct. 18, 2021, vaccine hesitancy persists.1 The U.S. Centers for Disease Control and Prevention (CDC), citing data from the U.S. Census Bureau’s Household Pulse Survey collected between May 26 and June 7, 2021, reports that in some U.S. counties—particularly in the Southeast…

    Vaccine Hesitancy: Wariness Is Rare, But There’s a Wider Worry About COVID Vaccines’ Efficacy in Some Populations

    July 6, 2021

    Hesitancy about COVID-19 vaccination persists nationwide, although it varies among regions and sociodemographic groups.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences